Evidence map›Paper›PMID 35447937›Full record

ArticleMarine drugs2022

Evaluation of the Potential of Lipid-Extracted

Guillaume Delfau-Bonnet, Nabila Imatoukene, Tiphaine Clément, Michel Lopez, Florent Allais, Anne-Lise Hantson

Abstract read
In one paragraph

Article in Marine drugs, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Frontiers in nutrition · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Guillaume Delfau-BonnetChemical and Biochemical Process Engineering Unit, Faculty of Engineering, University of Mons, 7000 Mons, Belgium.ORCID 0000-0003-3155-7218
Nabila ImatoukeneUnite Recherche et Developpement Agro-Biotechnologies Industrielles (URD ABI), Centre Europeen de Biotechnologie et Bieconomie (CEBB), AgroParisTech, 51110 Pomacle, France.ORCID 0000-0003-4855-0696
Tiphaine ClémentUnite Recherche et Developpement Agro-Biotechnologies Industrielles (URD ABI), Centre Europeen de Biotechnologie et Bieconomie (CEBB), AgroParisTech, 51110 Pomacle, France.
Michel LopezUnite Recherche et Developpement Agro-Biotechnologies Industrielles (URD ABI), Centre Europeen de Biotechnologie et Bieconomie (CEBB), AgroParisTech, 51110 Pomacle, France.ORCID 0000-0003-0053-2616
Florent AllaisUnite Recherche et Developpement Agro-Biotechnologies Industrielles (URD ABI), Centre Europeen de Biotechnologie et Bieconomie (CEBB), AgroParisTech, 51110 Pomacle, France.ORCID 0000-0003-4132-6210
Anne-Lise HantsonChemical and Biochemical Process Engineering Unit, Faculty of Engineering, University of Mons, 7000 Mons, Belgium.

Funding

European Regional Development Fund (ERDF) Interreg France-Wallonia-Vlaanderen program (project ALPO)
6 · The paper itself

Abstract

Projections show that the cultivation of microalgae will extend to the production of bio-based compounds, such as biofuels, cosmetics, and medicines. This will generate co-products or residues that will need to be valorized to reduce the environmental impact and the cost of the process. This study explored the ability of lipid-extracted

Indexed as

Chlorella vulgarisMicroalgaeYarrowiaBiofuelsBiomassFatty AcidsHydrogen-Ion ConcentrationLipidsBiofuelsFatty AcidsLipidsChlorella vulgarisfatty acidsgrowthYarrowia lipolytica

Identifiers

PMID35447937
PMCPMC9024751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.